MedPath

Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy

Not Applicable
Not yet recruiting
Conditions
Tissue Adhesion
Registration Number
NCT07132892
Lead Sponsor
Jeffrey M. Kenkel
Brief Summary

The study is being conducted to objectively assess tissue changes following the use of P4HB in rhytidectomy to understand how the utilization of the surgical mesh may affect tissue mechanical strength and elasticity, wound healing, and scar formation dynamics.

Detailed Description

This is a prospective study designed to follow six (6) qualified and consenting adults, 18-80 years of age scheduled for an elective rhytidectomy with the Principal Investigator (PI). Subjects will be evaluated at baseline, month 1, month 6 and month 12. The effects of the study device will be analyzed at all follow up visits through clinical/3D photography, non-invasive skin assessments and subject/physician questionnaires. The PI will be collecting tissue samples during their surgical procedure, month 6 and month 12 visits. Histopathology will be completed on the collected sample to assess changes of the tissue after the subjects rhytidectomy.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
UltrasonographyBaseline, Month 3 and Month 6 and Month 12

Ultrasonography will be used to evaluate the skin thickness and density for research purposes.

Bio-mechanical Tissue CharacterizationBaseline, Month 3 and Month 6 and Month 12

BTC will be used to measure skins laxity, viscoelasticity deformation, stiffness, energy absorption, elasticity, and deformation values for research purposes.

Change from baseline will be calculated to assess change

Secondary Outcome Measures
NameTimeMethod
Instron Biomedical TestingBaseline, Month 6 and Month 12

The Instron device measures the mechanical properties of the tissue.

Face-Q: Satisfaction with Facial AppearanceBaseline, Month 6 and Month 12

scale that measures a patient's overall satisfaction with how their face looks. It assesses things like symmetry, harmony, proportion, and vitality.

A scale that measures a patient's overall satisfaction with how their face looks. It assesses things like symmetry, harmony, proportion, and vitality.

A score from 0 to 100, where a higher score indicates a better outcome or greater satisfaction

Face-Q: Satisfaction with OutcomeBaseline, Month 6 and Month 12

A series of positively worded questions to ask patients directly how they feel about the outcome.

A score from 0 to 100, where a higher score indicates greater satisfaction with the outcome.

Histological AssessmentBaseline, Month 6 and Month 12

Tissue will be obtained, for research purposes, to assess histological evaluation assessment.

Change from baseline will be calculated to assess change

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.